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1. SUMMARY 
 
Title: Cognitive-Behavioural Therapy of Obsessive-Compulsive Disorder 
 
Author: Veronika Nives Zoric  
 
Obsessive-Compulsive disorder is a severe and debilitating psychiatric disorder 
affecting more and more people worldwide. As the fourth most common psychiatric disorder, 
its history can be traced back to the 16th century. Although previously classified as an anxiety 
disorder in DSM-IV, it has recently been given its own chapter with related disorders in 
DSM-5. In ICD-10, OCD is grouped with neurotic, stress-related and somatoform disorders, 
and given the code F42. ICD-10 subdivides OCD into three types: predominantly obsessive 
type, predominantly compulsive type, and the most commonly found mixed type. Obsessions 
can be defined as repetitive and persistent thoughts or feelings that are viewed by the patient 
as intrusive and inappropriate and cause marked anxiety or distress. Typical obsessions 
include: fears of being contaminated by germs or poisons, fears of causing harm to oneself or 
others, and fears of committing some unacceptable action. Compulsions, on the other hand, 
are repetitive acts or behaviours that the patient deems necessary to perform as a response to 
an obsession, and which serve to reduce anxiety. Common compulsions include: excessive 
washing and cleaning, checking, seeking reassurance, hoarding objects, and insisting that 
things be put in a specific order or pattern. Based on the severity of symptoms OCD can be 
divided into mild, moderate and sever forms. Many theories exist on the etiology of OCD, but 
no theory is regarded as the sole etiologic factor. Comorbidity with other psychiatric disorders 
is common, with a lifetime history of major depression present in two thirds of OCD patients. 
An array of different psychiatric and neurologic disorders must be taken into account in the 
differential diagnosis of OCD such as: specific phobias, major depressive disorder, 
trichotillomania, hoarding disorder, tic disorders, and obsessive-compulsive personality 
disorder. The primary goal of treatment in the majority of OCD cases is to have the individual 
control the disorder rather than the obsessional disorder control the individual. Safe and 
effective first-line treatment for OCD includes cognitive-behavioural therapy (CBT) and 
pharmacotherapy with selective serotonin reuptake inhibitors (SSRIs). Severe and drug-
resistant cases can be managed with electroconvulsive therapy and rarely, surgery. The course 
of the disease is chronic, and the quality of life largely depends on the severity of symptoms 
and the response to therapy. 
 
Keywords: obsessive-compulsive disorder, differential diagnosis, pharmacotherapy, 
cognitive-behavioural therapy 
2. SAŽETAK 
 
Naslov: Kognitivno-behavioralna terapija opsesivno-kompulzivnog poremećaja 
Autor: Veronika Nives Zorić 
 
Opsesivno-kompulzivni poremećaj (OKP) je teški i debilitativni psihijatrijski 
poremećaj koji utječe na sve više i više ljudi širom svijeta. Kao četvrti najčešći psihijatrijski 
poremećaj, njegova povijest se može pratiti do 16. stoljeća. Iako je prethodno klasificiran kao 
anksiozni poremećaj u DSM-IV, nedavno je dobio vlastito poglavlje s povezanim 
poremećajima u DSM-5. Kod ICD-10, OKP je grupiran s neurotskim, stresnim i 
somatoformnim poremećajima, te dodijeljen kod F42. ICD-10 dijeli OKP u tri tipa: pretežno 
opsesivno tip, pretežno kompulsivan tip i najčešće pronađen mješoviti tip. Opsesije se mogu 
definirati kao ponavljajuće i perzistentne misli ili osjećaje koje pacijent doživljava kao 
intruzivne i neprimjerene te koji uzrokuju ozbiljnu tjeskobu ili nelagodu. Tipične opsesije 
uključuju: strah od onečišćenja ili kontaminacije, strahovanja od nanoseći zla sebe ili 
drugima, i strah od počinjenja nekog neprihvatljivog djelovanja. S druge strane, Kompulzije 
ili prisile su ponavljajuća djela ili ponašanja koji pacijent smatra potrebnim za obavljanje kao 
odgovor na opsesiju, a koji služe za smanjenje anksioznosti. Uobičajene prisile uključuju: 
pretjerano pranje i čišćenje, provjeravanje, traženje sigurnosti, sakupljanje predmeta i 
inzistiranje na tome da se stvari stave u određeni red. Mnoge teorije postoje na etiologiji OKP, 
ali niti jedna teorija ne smatra se superiorna nad ostalim. Komorbiditet s drugim 
psihijatrijskim poremećajima je uobičajen, s dugotrajnom poviješću velike depresije prisutne 
u dvije trećine pacijenata s OKP. Različiti psihijatrijski i neurološki poremećaji moraju se 
uzeti u obzir u diferencijalnoj dijagnozi OKP-a, kao što su: specifične fobije, depresija, 
trichotilomania, patološko skupljanje, tic poremećaji i opsesivno-kompulzivni poremećaj 
ličnosti. Primarni cilj liječenja je da pojedinac kontrolira poremećaj, a ne da poremećaj 
kontrolira pojedinca. Sigurno i učinkovito prvoklasno liječenje OKP-a uključuje kognitivno-
bihevioralnu terapiju (KBT) i farmakoterapiju sa selektivnim inhibitorima ponovne pohrane 
serotonina (SIPPS). Teški slučajevi otporni na lijekove mogu se liječiti elektrokonvulzivnom 
terapijom, a rijetko, kirurški. Tijek bolesti je kroničan, a kvaliteta života uvelike ovisi o težini 
simptoma i odgovoru na terapiju. 
 
Ključne riječi: opsesivno-kompulzivni poremećaj, diferencijalna dijagnoza, farmakoterapija, 
kognitivno-bihevioralna terapija 
3. INTRODUCTION 
 
Obsessive-compulsive disorder has a long history stretching back to the sixteenth century. 
Shakespeare himself incorporated the disorder in his play Macbeth. In the play, the character 
of Lady Macbeth washes her hands repeatedly in an effort to reduce her distress after she 
prods her husband to murder Scotland’s king. Even earlier, people with obsessions and 
compulsions were believed to be possessed by the devil. Exorcism was the treatment of 
choice, during which the person was subjected to torture in order to drive out the intruding 
entity. By the 1700s, the cause of obsessions and compulsions moved from a religious to a 
medical view. Doctors began performing procedures such as bloodletting in an attempt to try 
and cure their patients from obsessive thoughts. In the 1800s, it became much more common 
to institutionalize the mentally ill, and this unhappy development also affected many OCD 
sufferers. In 1838, obsessions and compulsions were first described in psychiatric literature by 
French physician J.E.D. Esquirol, and were regarded as manifestations of melancholy or 
depression. By the beginning of the twentieth century, the view of OCD had shifted toward a 
psychologic explanation. This was partly due to the French psychiatrist Pierre Janet and the 
Austrian psychiatrist Sigmund Freud. Sigmund Freud attributed obsessive–compulsive 
behaviour to unconscious conflicts that manifest as symptoms. He conceptualized the disorder 
as a conflict between the ego and superego, or aggressive and sexual impulses emerging from 
the id manifesting symptoms of obsessions as a punishment sent by the superego (Kempke & 
Luyten, 2007). In the last decades of the twentieth century, with the development of modern 
neuroimaging and neurochemical methods, the biology of this disorder began to be explored. 
Today a variety of models and hypotheses have been proposed in an attempt to explain the 
development of OCD including the serotonin hypothesis, neuroanatomical models, and 
behavioural theories. Several different lines of research also point towards genetic factors. 
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OCD is a condition in which the patient has either obsessions, compulsions, or both. These 
can be so frequent or intense that they interfere with the patients social or role functioning. 
The first symptoms usually appear in early adulthood and have an impact on the patient’s 
quality of life. OCD is the fourth most common psychiatric disorder in the population and 
thus represents a social and economic burden in today's society. It is usually a chronic 
disorder, but with the help of today's pharmacological and psychotherapy approaches, 
symptoms can be controlled and the disorder managed.   
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4. EPIDEMIOLOGY 
 
OCD was once thought to be a rare disorder in the general population. This perception 
was based on an epidemiologic study by Rudin, who estimated OCD prevalence to be 5 in 
10,000 in the general population (Stein et al., 2010). Several studies completed in the late 
1950s and early 1960s examined the frequency of psychiatric diagnoses of OCD in inpatient 
and outpatient settings and further reinforced this false belief. The two largest epidemiolgical 
studies by Karno et al. in 1988 and Weissman et al. in 1994 utilized trained lay interviewers to 
administer a structured diagnostic interview. They found that the one year OCD prevalence 
rates ranged from 0.8 % to 2.3 % (URL-1). However, the most recent epidemiological data 
from DSM-5 indicates that the 12-month prevalence of OCD in the United States is 1.2 %, 
with a similar prevalence internationally: 1.1 - 1.8 % (DSM-5, 2013). Females are affected at 
a slightly higher rate than males in adulthood, although males are more commonly affected in 
childhood. The first symptoms of OCD usually appear before the age of 25 in more than two 
thirds of cases, while for less than 15 % of patients they appear after the age of 35 
(Rasmussen and Eisen, 1992). The course of the disorder when untreated is generally chronic, 
with waxing and waning of symptoms. Some individuals have an episodic course, and a 
minority have a deteriorating course. Stress appears to exacerbate the condition. Many adults 
with the disorder have a lifetime diagnosis of an anxiety disorder (76 %; e.g., panic disorder, 
social anxiety disorder, generalized anxiety disorder, specific phobia) or a depressive or 
bipolar disorder (63 % for any depressive or bipolar disorder, with the most common being 
major depressive disorder - 41 %)(DSM-5, 2013). Up to 30 % of individuals with OCD also 
have a lifetime tic disorder. A comorbid tic disorder is most common in males with onset of 
OCD in childhood.   
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5. ETIOLOGY 
 
The etiology of OCD is still a mystery for doctors today. There are many theories on what 
might be the cause OCD, but no theory is regarded as the sole etiologic factor. 
 
5.1. Psychological Etiologies 
 
5.1.1. Psychodynamic Theory 
 
This theory was created by Freud in an attempt to explain the symptoms of OCD. He focused 
his attention on the mother-infant interaction and considered issues of aggression and 
autonomy to be paramount around the time of toilet training, when the child strives to hold on 
to valuable feces and the mother requests that he give them up to please her. Freud developed 
concepts of anality and anal sadism and proposed that hostile impulses against the parents 
were controlled by obsessive-compulsive behaviour (Jenike et al., 1998). 
 
5.1.2. Behavioural Theory 
 
The behavioural conceptualization of OCD emphasizes the role of conditioning in the 
development and maintenance of the disorder (Salkovskis & Kirk, 1989). According to this 
theory, obsessions are produced when a previously neutral object becomes associated with a 
stimulus that produces fear. Compulsions follow as the individual attempts to reduce the 
anxiety produced by the learned fearful stimulus. Avoidance of the object and performance of 
compulsions reinforces the fear and perpetuates the vicious cycle of OCD. 
 
5.1.3. Cognitive Theory 
 
A primary feature of this model is that particular types of intrusive thoughts, upon appraisal, 
will interact with beliefs of responsibility in vulnerable individuals and lead to behaviours 
designed to neutralize the threat posed by the obsessional thought. Central to this theory is the 
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notion of responsibility. Salkovskis and Kirk place particular emphasis on resonsibility, 
pointing out that schemas of danger, in the absence of percieved responsibility, will lead to 
other forms of anxiety disorders other than OCD (Salkovskis & Kirk, 1997). 
 
5.2. Biological Etiologies 
 
In 1964, several studies were conducted to observe the relationship between neurologic illness 
and obsessional disorders. Grimshaw studied 103 obsessional patients and reported that 19.4 
% had a history of neurologic illness compared with only 7.6 % of a control group of 105 
normal subjects (a significant differnce; p=0.05) (Grimshaw, 1964). 
 
5.2.1. Immunologic Hypothesis 
 
In Grimshaw's study, six OCD patients had serious central nervous system infections, eight 
had a history of convulsive disorder and six patients had a history of chorea consistent with 
Syndehams chorea. In a more recent study by Rapoport, approximately 20 % of rheumatic 
fever patients develop Syndenham's chorea, probably as a result of an autoimmune response 
to the basal ganglia, leading to potential damage in that area (Rapoport, 1989). Obsessional 
symptoms were significantly higher among those patients with Sydenham's chorea. In 
children, such symptoms have been called paediatric autoimmune neuropsychiatric disorders 
associated with streptococcal infections (PANDAS). It is believed that this results when 
antibodies directed against invading streptococcus bacteria cross-react with basal ganglia 
structures, resulting in onset or exacerbation of OCD or tic disorder. 
 
5.2.2. Association with Hypothalamic Lesions 
 
A study conducted by Pitman, using rats, showed that bilateral hippocampal lesions produce 
repetitive behaviours, invariability, excesiveness, retarded extinction, and improved shuttle-
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box avoidance (Pitman, 1982). He believed that the symptoms in the animals were not 
coincidental and that there is a similarity between the symptoms and behaviour of OCD 
individuals. 
 
5.2.3. Metabolic Changes in Corticostriatal Circuitry 
 
Neuroimaging studies of OCD have shed considerable light on the neuroanatomical structures 
involved in the expression of OCD. Functional imaging studies have shown increased activity 
in the corticostriatal pathway involving anterior/lateral orbitofrontal cortex and the caudate 
nucleus, which is accentuated during symptom provocation and attenuated following effective 
treatment. (Jenike et al., 1998). 
 
5.2.4. Amygdalocentric Models  
 
The amygdala is one of two almond-shaped groups of nuclei located deep and medially within 
the temporal lobes of the brain. It is a structure that has been implicated in emotional fear 
conditioning. Through the evidence collected from various animal studies, it has been 
proposed that the amygdala is a key neuroanatomic substrate of the anxiety that perpetuates 
compulsions in OCD (Whalen and Kapp, 1991). 
 
5.2.5. The Serotonergic Hypothesis  
 
Serotonin is a monoamine neurotransmitter that is primarily thought to be responsible for 
feelings of well-being and happiness. The serotonin hypothesis suggests that 5HT 
dysregulation may be etiologically linked to OCD. Although there is not yet any compelling 
data to support this hypothesis, serotonergic medication have been proven to be effective as 
treatments for OCD. One study found that the therapeutic effects of 5HT are correlated with 
changes in peripheral parameters of function, which have been found to be altered in OCD, 
suggesting the possibility of reduced 5HT reuptake capacity. This could reflect a 
6 
 
compensatory mechanism presumably due to decreased availability of extracellular 5HT, as 
evidenced by data derived from direct assessment of central 5HT neurotransmission 
(Aouizerate et al., 2005). 
 
5.2.6. The Glutamatergic Hypothesis 
 
Recent evidence suggests that the excitatory neurotransmitter glutamate is dysregulated in 
OCD. The most direct evidence for excessive glutamatergic activity in OCD derives from a 
recent study examining CSF from patients with OCD. Chakrabarty et al.examined the CSF of 
21 drug-naive OCD patients and 18 control subjects, and found CSF glutamate levels to be 
significantly elevated in those subjects with OCD. (Chakrabarty et al., 2005). 
 
5.2.7. Genetics 
 
The evidence for possible genetic predisposition in OCD derives from two sources: twin 
studies and investigations of the first degree relatives of OCD sufferers. To date, the largest 
and most statistically robust twin study found a monozygotic twin concordance rate of 0.52 
and a dizygotic concordance rate of 0.21, with overall heritability for OCD estimated to be  48 
% (Brown et al., 2014). Furthermore, first degree relatives of patients with OCD are more 
likely to suffer from OCD than are the relatives of psychiatric controls. Recurrence risk 
among first-degree relatives for lifetime OCD estimates to be as low as 6 % to as high as     55 
%, with the majority of estimates falling between about 10 and 20 % (Brown et al., 2014). 
These estimates are significantly higher than the lifetime prevalence for OCD in the general 
population, which is estimated to be 0.7-3 % (Brown et al., 2014). Overall, the evidence 
suggests that genetic factors play a role in the disorder. 
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6. CLINICAL PICTURE 
 
OCD is a condition in which the patient has either obsessions, compulsions, or both. 
These can be so frequent or intense that they interfere with the patients social or role 
functioning. Obsessions are recurrent and persistent thoughts, urges, or images that are 
experienced as intrusive and unwanted, whereas compulsions are repetitive behaviours or 
mental acts that an individual feels driven to perform in response to an obsession, or 
according to rules that must be applied rigidly (DSM-5, 2013). As well as being intrusive and 
unwanted, obsessions cause marked distress and anxiety in most individuals. Typical 
obsessions include: fears of being contaminated by germs or poisons, fears of causing harm to 
oneself or others, and fears of committing some unacceptable action. While on the other hand, 
compulsions are typically performed in response to an obsession with the aim of reducing the 
distress or to prevent a feared event (Leahy et al., 2012). Usual compulsions include: 
excessive washing and cleaning, checking, seeking reassurance, hoarding objects, and 
insisting that things be put in a specific order or pattern. The majority of pateints have both 
obsessions and compulsions. It is common for individuals with the disorder to avoid people, 
places, and things that trigger obsessions and compulsions. Comorbidity with other 
psychiatric disorders is common, with a lifetime history of major depression present in two 
thirds of OCD patients. Suicidal thoughts occur at some point in as many as about half of 
individuals with OCD. Suicide attempts are also reported in up to one-quarter of individuals 
with OCD; the presence of comorbid major depressive disorder increases the risk (DSM-5, 
2013). This disorder also coexists with a number of other Axis I disorders including panic 
disorder, social phobia, eating disorders, and Tourette's disorder (Rasmussen & Eisen, 1992). 
A clinician administered rating scale exists called the Y-BOCS. It has become the most 
widely used rating scale for OCD and is designed to rate symptom severity, not to establish a 
diagnosis. The Y-BOCS provides five rating dimensions for obsessions and compulsions: 
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time spent or occupied, interference with functioning or relationships, degree of distress, 
resistance, and control (i.e., success in resistance). The 10 Y-BOCS items are each scored on 
a four-point scale from 0 = no symptoms to 4 = extreme symptoms. The sum of the first five 
items is a severity index for obsessions, and the sum of the last five an index for compulsions. 
A translation of total score into an approximate index of overall severity is: 0-7 = subclinical, 
8-15 = mild, 16-23 = moderate, 24-31 = severe, 32-40 = extreme (URL-2). The scale is useful 
as an initial assessment of the severity of OCD, and also as a tool to further follow the patient 
and their response to therapy.   
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7. DIAGNOSIS 
 
The diagnosis of OCD is made when the patient fulfills the diagnostic criteria in anyone of the 
psychiatric diagnostic manuals that are currently being used. 
 
7.1. ICD-10 
 
Grouped with neurotic, stress-related and somatoform disorders, OCD is given the code F42. 
OCD with predominantly obsessional thoughts or ruminations is given the code F42.0, while 
the form with predominantly compulsive actions (obsessional rituals) is F42.1. The most 
common form is the mixed form, and this can be found under code F42.2. 
 
7.2. DSM-5 
 
Compared to the previous DMS-IV version, in DMS-5 OCD has been given its own chapter 
with related disorders. These include: body dysmorphic disorder, hoarding disorder, 
trichotillomania, excoriation disorder, substance/medication-induced obsessive-compulsive 
and related disorder, obsessive-compulsive and related disorder due to another medical 
condition, and other specified obsessive-compulsive and related disorder and unspecified 
obsessive-compulsive and related disorder (e.g., body-focused repetitive behavior disorder, 
obsessional jealousy). The diagnostic criteria of OCD according to DSM-5 are the following: 
 
A. Presence of obsessions, compulsions, or both: 
 
Obsessions are defined by (1) and (2): 
1. Recurrent and persistent thoughts, urges, or images that are experienced, at some time 
during the disturbance, as intrusive and unwanted, and that in most individuals cause 
marked anxiety or distress. 
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 2. The individual attempts to ignore or suppress such thoughts, urges, or images, or to 
neutralize them with some other thought or action (i.e., by performing a compulsion). 
  
Compulsions are defined by (1) and (2): 
1. Repetitive behaviors (e.g., hand washing, ordering, checking) or mental acts (e.g., 
praying, counting, repeating words silently) that the individual feels driven to perform 
in response to an obsession or according to rules that must be applied rigidly. 
 
2. The behaviors or mental acts are aimed at preventing or reducing anxiety or distress, 
or preventing some dreaded event or situation; however, these behaviors or mental 
acts are not connected in a realistic way with what they are designed to neutralize or 
prevent, or are clearly excessive. Note: Young children may not be able to articulate 
the aims of these behaviors or mental acts. 
 
B. The obsessions or compulsions are time-consuming (e.g., take more than 1 hour per day) 
or cause clinically significant distress or impairment in social, occupational, or other 
important areas of functioning. 
 
C. The obsessive-compulsive symptoms are not attributable to the physiological effects of a 
substance (e.g., a drug of abuse, a medication) or another medical condition. 
 
D. The disturbance is not better explained by the symptoms of another mental disorder (e.g., 
excessive worries, as in generalized anxiety disorder; preoccupation with appearance, as 
in body dysmorphic disorder; difficulty discarding or parting with possessions, as in 
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hoarding disorder; hair pulling, as in trichotillomania [hair-pulling disorder]; skin picking, 
as in excoriation [skin-picking] disorder; stereotypies, as in stereotypic movement 
disorder; ritualized eating behavior, as in eating disorders; preoccupation with substances 
or gambling, as in substance-related and addictive disorders; preoccupation with having 
an illness, as in illness anxiety disorder; sexual urges or fantasies, as in paraphilic 
disorders; impulses, as in disruptive, impulse-control, and conduct disorders; guilty 
ruminations, as in major depressive disorder; thought insertion or delusional 
preoccupations, as in schizophrenia spectrum and other psychotic disorders; or repetitive 
patterns of behavior, as in autism spectrum disorder). 
 
Specify if: 
With good or fair insight: The individual recognizes that obsessive-
compulsive disorder beliefs are definitely or probably not true or that they may 
or may not be true.  
With poor insight: The individual thinks obsessive-compulsive disorder 
beliefs are probably true.  
With absent insight/delusional beliefs: The individual is completely 
convinced that obsessive-compulsive disorder beliefs are true. 
Specify if:  
Tic-related: The individual has a current or past history of a tic disorder. 
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8. DIFFERENTIAL DIAGNOSIS 
 
Differential diagnosis of obsessive compulsive disorder includes: generalized anxiety 
disorder, specific phobias, major depressive disorder, trichotillomania, hoarding disorder, tic 
disorders, and obsessive-compulsive personality disorder. 
 
8.1. Generalized Anxiety Disorder 
 
Adults with GAD often worry about every day, routine life circumstances, such as possible 
job responsibilities, health, and finances, whereas children with the disorder tend to worry 
excessively about their competence or the quality of their performance. Although recurrent 
thoughts and repetitive behaviours can also occur in GAD, the recurrent thoughts are usually 
about real-life concerns and future events, whereas in OCD they can be odd and irrational in 
nature and take the form of intrusive and unwanted thoughts, urges, or images. As with OCD, 
individuals with GAD have excessive anxiety that often interferes with daily functioning. 
However, to make the diagnosis of GAD, the anxiety and worry need to be accompanied by at 
least three of the following additional symptoms: restlessness, being easily fatigued, difficulty 
concentrating or mind going blank, irritability, muscle tension, and disturbed sleep. 
 
8.2. Specific Phobias 
 
In specific phobias, there is marked fear or anxiety about a specific object or situation. Most 
common phobias include: fear of specific animals, natural environment, or blood-injection 
injury. As in OCD, the fear or anxiety in specific phobias is out of proportion to the actual 
danger that the object or situation poses, and the individual actively avoids the situation in 
order to avoid the anxiety associated with it. If an individual’s primary fear or anxiety is of an 
object or situation as a result of obsessions (e.g., fear of blood due to obsessive thoughts about 
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contamination from blood-borne pathogens [i.e., HIV]; fear of driving due to obsessive 
images of harming others), and if other diagnostic criteria for obsessive-compulsive disorder 
are met, then obsessive-compulsive disorder should be diagnosed (DSM-V, 2013). 
 
8.3. Major Depressive Disorder 
 
MDD is the most frequent comorbid condition in OCD. Most patients report the onset of 
depression after the appearance of the OCD (Kolada et al., 1994). The essential feature of a 
major depressive episode is a period of at least 2 weeks during which there is either depressed 
mood or the loss of interest or pleasure in nearly all activities. The individual must also 
experience at least four additional symptoms drawn from a list that includes changes in 
appetite or weight, sleep, decreased energy etc… 
 
8.4. Trichotillomania 
 
According to DSM 5, trichotillomania is characterized by recurrent pulling out of one's hair 
resulting in hair loss, and repeated attempts to decrease or stop hair pulling. The condition is 
found predominantly in females and it usually develops at an early age; from adolescence to 
early twenties. The compulsive behaviour in trichotillomania is limited to hair pulling, in the 
absence of obsessions. 
 
8.5. Hoarding Disorder 
 
Hoarding disorder is characterized by persistent difficulty discarding or parting with 
possessions. The main reasons given for these difficulties are the perceived utility or aesthetic 
value of the items or strong sentimental attachment to the possessions. In OCD, if there is 
acquisition of items, this is usually due to a specific obsession. Unlike in hoarding disorder, 
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these items are usually bizarre in nature and include: trash, feces, urine, nails, hair, used 
diapers, or rotten food. 
 
8.6. Tic Disorders 
 
A tic is a sudden, rapid, recurrent, nonrhythmic motor movement or vocalization. Tic 
disorders include: Tourette’s disorder, persistent (chronic) motor or vocal tic disorder, and 
provisional tic disorder. Differentiating obsessive-compulsive behaviors from tics may be 
difficult. Usually in OCD there is a cognitive based drive to the behaviour and the need to 
perform the action a certain number of times in a particular way. 
 
8.7. Obsessive-Compulsive Personality Disorder 
 
OCPD (DSM-IV) or Anankastic Personality Disorder (ICD-10, F60.5) can be divided into 
three subtypes: obsessional, compulsive, or obsessive-compulsive. This personality disorder is 
characterized by a general pattern of concern with orderliness, perfectionism, excessive 
attention to details, mental and interpersonal control, and a need for control over one's 
environment. These individuals are excessively careful and prone to repetition, paying 
extraordinary attention to detail and repeatedly checking for possible mistakes. OCPD is one 
of the most common personality disorders in the general population, being found twice as 
often in males. OCD is usually easily distinguished from obsessive-compulsive personality 
disorder by the presence of true obsessions and compulsions. 
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9. TREATMENT 
 
The primary goal of treatment in the majority of OCD cases is to have the individual 
control the disorder rather than the obsessional disorder control the individual. Achievement 
of this goal allows patients to reach their full potential and improve their quality of life and 
social or role functioning. The Y-BOCS scale is useful as an initial assessment of the severity 
of OCD, and also as a tool to further follow the patient and their response to therapy. If a 
rating scale is not used, it is helpful to document the patient’s estimate of the number of hours 
per day spent obsessing and performing compulsive behaviours and the degree of effort 
applied to trying to escape the obsessions and to resisting the behaviours. In choosing a 
treatment approach, the clinician should consider the patient’s motivation and ability to 
comply with pharmacotherapy and psychotherapy. Safe and effective first-line treatment for 
mild or moderate OCD includes cognitive-behavioural therapy (CBT) and selective serotonin 
reuptake inhibitors (SSRIs). Many patients with OCD also benefit from educational materials 
and access to support groups. According to the American Psychiatric Association, whether to 
utilize CBT, an SRI, or combined treatment will depend on factors that include the nature and 
severity of the patient’s symptoms, the nature of any co-occurring psychiatric and medical 
conditions and their treatments, the availability of CBT, and the patient’s past treatment 
history, current medications, capacities, and preferences (American Psychiatric Association, 
2007). The doses of the medications are higher than what is usually given in other anxiety or 
depressive disorders, and also the treatment lasts longer. If the first treatment attempt is 
unsuccessful, another drug or treatment option can be considered. It is important to be 
persistent and find the best treatment option for the patient.   
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9.1. Psychological Treatment 
 
9.1.1. Cognitive-behavioural Therapy 
 
Cognitive-behavioural therapy is the most effective evidence-based psychotherapy for OCD. 
It involves 2 components: cognitive reappraisal or restructuring and behavioural interventions, 
typically in the form of exposure and response prevention (ERP). The 2 components of CBT 
can be used either jointly or independently, although in practice, exposure-response 
prevention is the most frequently used approach (Hirschtritt et al., 2017). CBT has two 
general aims: controlling compulsive rituals and avoidance, and reducing the anxiety 
associated with obsessions, and through this, reducing their intensity and frequency. CBT 
alone is recommended as initial treatment for a patient who is not too depressed, anxious, or 
severely ill to cooperate with this treatment modality, or who prefers not to take medications 
and is willing to do the work that CBT requires. In one study, ERP was found to be superior 
to clomipramine and to a pill-placebo (Foa et al., 2005). Combined treatment, of CBT and 
pharmacotherapy, should be considered for patients with an unsatisfactory response to 
monotherapy, for those with co-occurring psychiatric conditions for which SSRIs are 
effective, and for those who wish to limit the duration of SSRI treatment. According to Foa, 
ERP combined with medication was also more efficacious than either medication alone (Foa 
et al., 2005).  Literature also demonstrates that CBT is effective regardless of baseline 
symptom severity, symptom subtype, gender, number of sessions, or comorbidity profile 
(Olatunjiet al., 2013). However, there are some barriers to CBT treatment, including lack of 
availability (eg, few local clinicians, especially those trained in OCD-specific approaches), 
intense time requirements (typically 1 or more hours a week for therapy sessions, plus daily 
“homework” assignments during at least 12 weeks),and patient motivation to engage in CBT 
(Hirschtritt et al., 2017).  Nonetheless, despite these barriers, no other psychosocial 
intervention has so consistently outperformed other treatment modalities. 
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9.1.1.1. Behavioural Treatment 
 
Behavioural treatment was introduced in 1966 by Meyer, who described two patients 
successfully treated with a behavioural therapy program that included prolonged exposure to 
distressing objects and situations, combined with strict prevention of rituals (exposure and 
response prevention). Mayer continued to implement this treatment program with additional 
OCD patients, and found that it was highly successful in 10 of 15 cases, and partially effective 
in the remaining patients. Moreover, 5 years later, only two of the patients in the case series 
had relapsed (Meyer, 1974). The goal of exposure and response prevention is to break the 
cycle of conditioning that maintains the disorder. While the exact mechanisms of this 
treatment are unknown it is hypothesized that ERP for OCD is effective because of the 
resultant 1) cognitive change (correction of faulty assumptions); 2) habituation to the 
conditioned fear; or 3) increases in self-efficacy (Abramowitz, 2006). If exposure is done long 
enough and frequent enough, the patient’s anxiety will decrease. However, for exposure to be 
effective patients must be prevented from performing rituals, otherwise they will use the 
rituals to manage their anxiety during exposure. The first step in exposure is to create a 
hierarchy of the patient’s obsessive thoughts and situations that are avoided. These are then 
ranked from least anxiety-provoking to the most. The exposure exercises typically begin with 
the lowest-ranking item on the hierarchy in the presence of the therapist, either in the 
consulting room, in the form of imaginal exposure, or in an actual situation (that is, in vivo 
exposure). Throughout the exposure, the patient is asked to rate his or her anxiety, from 0 to 
10, on the subjective units of distress scale (SUDS). Exposure is continued until the patients 
anxiety is reduced, ideally by at least half on the SUDS. At the end of each treatment session, 
the therapist instructs the patient to continue exposure for several hours alone and in different 
environmental contexts. After the first item on the hierarchy has been mastered, exposure to 
the next item is begun. Deciding between imaginal or in vivo exposure will depend upon the 
18 
 
patient’s obsessions. If the patient has fears of committing some unacceptable action or some 
catastrophe (e.g., family member being killed), imaginal exposure should be performed. In 
this case, a scenario can be created in which the patient’s fears come true. The session could 
be tape recorded so that the patient can listen to it repeatedly, in the session and at home, until 
their anxiety decreases on the SUDS. Other obsessions are most easily accessed with in vivo 
exposure. This is common when patients have a fear of contamination. In such cases the 
patient is put into contact with the feared situation (e.g., touching a doorknob) and then urged 
not to perform the compulsion or ritual (e.g., hand washing). This type of response prevention 
is key, and patients should be prevented from performing rituals not only during exposure 
session, but also throughout the day. It is common for patients to have some lapses in 
response prevention during treatment, and it is advised for the patient to continue to log all 
rituals. In some cases it may be helpful to involve family members so that they could remind 
the patients to forgo the rituals and also refuse to help and provide reassurance. One highly 
successful format for ERP comprises a few hours of assessment and treatment planning 
followed by 16 twice-weekly treatment sessions lasting about 90 to 120 minutes each and 
spaced over about 8 weeks (Abramowitz et al., 2003). In reviewing the results of more than 
200 OCD patients treated with behaviour therapy in several countries, Foa et al. reported that 
51 % of sufferers achieved at least a 70 % reduction in symptoms. Thirty-nine percent of 
patients achieved reductions ranging from 31 % to 69 %, and 10 % were considered failures, 
failure being defined as patients with an improvement of 30 % or less (Foa et al., 1985). 
 
9.1.1.2. Cognitive Therapy 
 
Cognitive therapy (CT) is designed to help patients identify their automatic unrealistic 
thoughts and change their interpretations of the meaning of the thoughts, thus ultimately 
leading to a decrease in anxiety and compulsions. In the first stage of CT, patients are taught 
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to develop an awareness of their worries as obsessions and their rituals as compulsions. They 
are instructed to keep a daily diary of obsessions, called a thought record, where they can 
write down their obsessions, any interpretations, what they were doing when the obsession 
began, and their response to the obsession. The therapist then reviews this record with the 
patient and addresses the interpretation of the obsessions. Using gentle reasoning and Socratic 
questioning, the therapist will verbally challenge an unrealistic belief. This helps the patient to 
identify the cognitive distortion, typically a faulty assessment of danger, an exaggerated sense 
of responsibility, or fears that thinking something negative will make it come true (thought-
action fusion) (Foa, 2010). Once patients are able to quickly identify their obsessions and 
compulsions as symptoms of OCD, the therapist will initiate a few behavioural experiments to 
disprove errors in thinking about cause and effect. For example: if a patient believes that 
closing the door five times will prevent their family from being in a car crash, the therapist 
may instruct the patient to close the door four times and to see if any harm will come to their 
family. The results of this experiment could further be used to asses other unrealistic thoughts 
and over time patients will learn to independently identify and re-evaluate their faulty beliefs. 
 
9.1.1.2.1. Danger Ideation Reduction Therapy 
 
In practise explicitly cognitive techniques are used to challenge inflated responsibility, 
overestimation of threat, thought-action fusion, perfectionism and other maladaptive 
appraisals thought to maintain OCD. A novel cognitive intervention called Danger Ideation 
Reduction Therapy (DIRT) was evaluated in a pair of Australian studies (Jones and Menzies, 
1998; Krochmalik et al., 2004). DIRT targets danger-related cognitions regarding 
contamination while avoiding any behavioural strategies. It is based on the rationale that the 
therapist should provide as much factual information as possible. DIRT consists of six 
discrete treatment components aimed at reducing the number of intrusive thoughts 
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experienced and concurrently allowing the patient to successfully change the remaining 
thoughts and beliefs. The treatment includes: attentional focusing, filmed interviews, 
corrective information, cognitive restructuring, expert testimony, microbiological experiments 
and a probability of catastrophe assessment task (Jones and Menzies, 1998). In the study 
conducted by Jones and Menzies, DIRT showed significantly greater reductions in 
symptomatology from pre-treatment to after treatment on all four outcome measures than 
subjects who did not receive DIRT (Jones and Menzies, 1998). The second study by 
Krochmalik et al., also confirmed the hypothesis that DIRT represents a viable alternative to 
the standard behavioural approach to OCD. Indeed, DIRT was not only associated with 
significant reductions in OCD symptomatology, it also outperformed ERP on the most widely 
used measures in the assessment of this disorder (Krochmalik et al., 2004).The fact that DIRT 
was superior to comparison conditions in two studies confirms its effectiveness for patients 
with the contamination/washing subtype of OCD. 
 
9.1.2. The Future of CBT: Remote Treatment 
 
Recent research has focused on improving dissemination of CBT with technology or internet 
based delivery. Using these technology aids the patient and the therapist interact in real-time 
without having to be face to face. Evidence from various studies suggests that remote CBT 
demonstrates efficacy similar to that of in-person treatment. Remote treatment does not 
require the patient to attend traditional face-to-face treatment services and is thus important 
for those individuals who avoid seeking treatment because of stigma or have a preference to 
self-manage symptoms. Furthermore, not only does this type of treatment reduce the therapist 
time that is required to treat the patients, but it also provides the potential for considerable 
cost savings to healthcare providers. Typical technologies that are used in remote treatment 
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include traditional or internet-based videoconferencing, the telephone, computerized CBT, 
and programs accessed via the internet. 
 
9.1.2.1. Videoconferencing administered CBT (vCBT) 
 
Videoconferencing delivered CBT involves the client and the therapist interacting via a video-
link, thus the client's non-verbal behaviours are able to be observed. In one study conducted 
by Stubbings et al., CBT via videoconference was evaluated in the treatment of mood and 
anxiety disorders. The findings of this controlled trial indicated that CBT was effective in 
significantly reducing symptoms of depression, anxiety, and stress and increasing quality of 
life in both in-person and videoconferencing conditions, with no significant differences being 
observed between the two (Stubbings et al., 2013). 
 
9.1.2.2. Telephone administered CBT (tCBT) 
 
Telephone administered CBT interventions involve the client and therapist interacting over 
the telephone. Studies comparing tCBT with face-to-face CBT have emerged in both 
adolescent (Turner et al., 2014) and adult (Lovell et al., 2006) samples. Both studies 
demonstrate equivalent outcomes across methodologies and have found tCBT to be an 
effective treatment and not inferior to standard clinic-based CBT. 
 
9.1.2.3. Computerized CBT (cCBT) 
 
Computerized treatments are those that consist of a treatment program that is usually loaded 
on to a single computer or are administered via a computerized device. The most commonly 
used computerized program for the treatment of OCD is the Behaviour Therapy (BT) Steps 
program. Individuals access the computer generated program via a touch tone telephone rather 
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than a computer, and they advance through each of the steps at their own pace (Wootton, 
2013). In the study conducted by Greist et al., 218 OCD patients at 8 North American sites 
were randomly assigned to 10 weeks of behaviour therapy treatment guided by either a 
computer accessed by telephone and a user workbook, a behaviour therapist, or systematic 
relaxation guided by an audiotape and manual. The results showed that by week 10, the mean 
change in score on the Y-BOCS was significantly greater in clinician-guided behaviour 
therapy (8.0) than in computer-guided (5.6), and changes in scores with both clinician-guided 
and computer-guided behaviour therapy were significantly greater than with relaxation (1.7), 
which was ineffective (Greist et al. 2002). Therefore although computer-guided behaviour 
therapy was effective, clinician-guided behaviour therapy was shown to be even more 
effective. 
 
9.1.2.4. Internet-administered CBT (iCBT) 
 
Internet-delivered treatments are those that have materials that are accessible via the internet 
and are thus generally more flexible than computerized treatments. iCBT can be delivered as 
open access programs (where anyone can access the program) or can be closed (where the 
patient logs in with a secure username and password). 
 
9.1.2.5. Bibliotherapy administered CBT (bCBT) 
 
Bibliotherapy is a remote treatment where the individual is provided with a printed workbook 
to conduct his or her own treatment. It involves teaching the individual the same skills and 
techniques taught in face-to-face treatment, however, material is presented in a paper 
workbook rather than online or via a computer 
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9.2. Biological Treatment 
 
9.2.1. Pharmacotherapy 
 
9.2.1.1. Selective Serotonin Reuptake Inhibitors 
 
Serotonin (5-hydroxytryptamine, 5-HT) is a neurotransmitter that influences multiple 
processes, including autonomic function, motor activity, hormone secretion, cognition, and 
complex processes associated with affection, emotion, and reward. SSRIs are believed to 
increase the extracellular level of the neurotransmitter serotonin by limiting its reabsorption 
into the presynaptic cell. The molecular target for SSRIs is the solute carrier family 6 
(neurotransmitter transporter, serotonin), member 4 (SCL6A4). It is responsible for 
terminating the action of 5-HT in the synaptic cleft (Sangkuhl et al., 2009). Released 
serotonin is transported back into the presynaptic terminals via this integral membrane 
protein. SSRIs compose first-line pharmacologic treatment for OCD.  Clinical practice 
guidelines suggest that optimal treatment for OCD involves using SSRIs at the maximal 
tolerated dose within the Food and Drug Administration dosing guidelines for at least 8 to 12 
weeks. Further evidence suggests that continuing SSRI medications for at least 6 to 12 months 
after response to treatment is advisable; withdrawing SSRIs at any point is likely associated 
with a significant risk of relapse (Hirschtritt et al., 2017). SSRIs are well absorbed from the 
gut and are primarily metabolized via hepatic route. They are associated with numerous drug 
interactions; most notably with MAO inhibitors. The combination of SSRIs and MAO 
inhibitors may trigger serotonin syndrome. Although the efficacy of the SSRIs is comparable 
to that of the tricyclic antidepressants (TCA), the SSRIs have significantly fewer side effects. 
They do not cause cardiac conduction abnormalities in overdose, are associated with fewer 
antimuscarinic side effects, and have low propensity to cause seizures. Gastrointestinal 
disturbances, such as nausea and diarrhea, usually occur at the beginning of treatment and 
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subside after the first week. Other adverse effects include: insomnia, sexual dysfunction, 
increased risk of bleeding (when taken with anticoagulation drugs), suicidal ideation, and 
serotonin syndrome with overdose. Because of their wide therapeutic index, most patients will 
have mild or no symptoms following moderate overdoses and rarely deaths occur. 
 
9.2.1.1.1. Fluoxetine (Prozac®, Fluval®, Portal®) 
 
The recommended dosage for adults is 20 mg daily. However, if after 2 weeks of treatment 
there is no significant improvement in OCD symptoms the dosage can be raised to a 
maximum of 60 mg. The efficacy of fluoxetine at three fixed doses (20, 40, and 60 mg) was 
examined in a multicenter trial by Tollefson et al., who reported symptom reduction of 32.1%, 
32.4%, and 35.1%, respectivey, as compared with 8.5% for placebo after a 13 week trial 
(Tollefson et al., 1994). In children (> 8 years old) and adolescents the starting dose is 10 mg, 
and the maximum daily dose is 20 mg. 
 
9.2.1.1.2. Escitalopram (Cipralex®, Citram®, Elicea®, Escital®, Zepira®, Serpentil®) 
 
The beginning dosage for adults is 10 mg once a day. Depending on the effects it has on the 
patient, the dosage could be increased to a maximum of 20 mg per day. Escitalopram 
discontinuation, particularly abruptly, may cause certain withdrawal symptoms such as 
electric shock sensations, dizziness, acute depressions and irritability, as well as heightened 
senses of akathisia. When discontinuing medication, the dosage should be decreased gradually 
through the course of two weeks in order the reduce withdrawal symptoms. 
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9.2.1.1.3. Sertraline (Zoloft®, Halea®, Luxeta®, Sonalia®) 
 
The recommended starting dosage for adults is 50 mg daily; with a maintanence dose of 50-
200 mg once a day. In children aged 6-12 the starting dose is 25 mg, while those aged 13-17 it 
is also 50 mg. Maintenance dose ranges from 25-200 mg for children aged 6-12, while those 
aged 13-17 follow the same maintenance dosage as adult. A large multicenter placebo 
controlled trial of fixed-dose sertraline (50, 100, 200 mg) found that doses of 50 mg and 200 
mg were significantly more effective than placebo in reducing obsessional symptoms (Greist 
et al., 1995). 
 
9.2.1.1.4. Paroxetine (Paroxin®, Seroxat®) 
 
The target dose is 40 mg once a day. Treatment begins with a daily dose of 20 mg, which is 
then increased for 10 mg increments at weekly intervals, according to clinical response and 
tolerability. Paroxetine has also been reported to be more effective than placebo in a 
multicenter trial but only at doses of 40 mg and 60 mg per day, with 20 mg being no different 
from placebo (Hollander et al., 2000). Paroxetine may increase the risk of suicidal thinking 
and behaviour in children and adolescents and should thus be avoided in this age group. 
 
9.2.1.1.5. Fluvoxamine (Fevarin®, Floxyfral®, Dumyrox®, Luvox®) 
 
The initial dose is 50 mg daily. This is then increased by 25 mg every 4-7 days until the 
maintenance dose of 100-300 mg is achieved. The FDA has added a black box warning for 
this drug in reference to increased risks of suicidal thoughts and behaviour in young adults 
and children. Fluvoxamine is not approved for use in all children. 
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9.2.1.2. Clomipramine (Anafranil®) 
 
Clomipramine is a tricyclic antidepressant that was discovered in 1964 and it is still being 
used today. The maximal daily dosage for adults is 250 mg, while for children it is 200 mg. It 
is a highly selective inhibitor of serotonin reuptake. It is also an antagonist/inverse agonist at 
the histamine H1 receptor, the muscarinic acetylcholine receptors and the α1 adrenergic 
receptor. These last three actions likely contribute to its adverse effects. Specifically, 
clomipramine has substantial anticholinergic effects, such as dry mouth, blurred vision, 
constipation, fatigue, tremor, and hyperhidrosis. Furthermore, clomipramine is associated 
with increased risk of arrhythmia and seizures at doses greater than 200 mg daily, thus 
requiring monitoring of serum concentration. Thus, clomipramine is most appropriate as a 
second-line treatment for patients who do not respond to SSRIs. 
 
9.2.1.3. Other Medication 
 
In the case of ineffective treatment with SSRIs or TCA, the following drugs can be added to 
therapy: Valproate (Depakine®), Lithium, or Carabamazepine (Tegretol®).  
 
9.2.2. Electroconvulsive Therapy 
 
Electroconvulsive therapy (ECT) is not currently used as a first-line treatment for obsessive-
compulsive disorder (OCD). However, several studies have reported its effectiveness in 
treating severe OCD, especially when first line therapies have failed. In one study by Liu 
Xiaohui et al., three patients with severe OCD were treated by modified bifrontal ECT after 
their first-line anti-OCD treatments (pharmacotherapy, behavioral therapy, and cognitive 
behavioral therapy) failed. The resultls showed that in all three cases, the patients' depressive 
symptoms improved considerably after the ECT procedures (Liu Xiaohui et al., 2014). 
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9.2.3. Surgical Treatment 
 
Surgery for OCD is reserved for patients with the most severe cases of the disease, refractory 
to pharmacotherapy and psychotherapy. To be referred to surgery, certain requirements must 
be met; the patient must have had adequate trials (at least 10 weeks at maximally tolerated 
dose) of clomipramine, fluoxetine, fluvoxamine, sertraline, paroxetine, and a monoamine 
oxidase inhibitor. Also all patients must have had extended trial of behaviour therapy 
consisting of a minimum of 20 hours of ERP (Jenike et al., 1998). Contraindications must also 
be taken into consideration such as: age below 18 or above 65, inability to comply with 
treatment, and previous diagnosis or neurosurgical procedure. Two methods of surgery are 
currently employed: one involves performing a lesion, and the other involves stimulation of 
target areas using deep brain stimulation (DBS). In a lesion, a radiofrequency unit is used to 
produce a thermal lesion of calculated volume. This is permanent and irreversible. In DBS an 
electrode is implanted at the site of the target and current is delivered through a pacemaker to 
alter the signals emanating from the target. Both this procedures are performed using 
stereotactic techniques which offer a high degree of accuracy (within 1-2mm) (Doshi, 2009). 
The four procedures currently being used are: anterior capsulotomy, cingulotomy, subcaudate 
tractotomy and limbic leucotomy. Unfortunately there have been few comparison studies of 
these operations, so no single procedure is classified as the best. The most commonly 
performed surgical procedure is bilateral cingulotomy. In one study by Jung et al., the Y-
BOCS fell by 48% (Jung et al., 2006). Some patients with only limited response to surgery 
report better response to pharmacotherapy and behavioural therapy post operatively (Spofford 
et al., 2014). The most common complications following surgery include: infection, 
haemorrhage, epileptic seizures, and weight gain. Some countries have abandoned 
neurosurgery altogether, while in others it is only used in a few centers. 
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9.3. Social Therapy 
 
Social therapy is a particular kind of group therapy. The group consists of people of various 
backgrounds, histories and ages. While traditional therapies typically focus on the individual, 
social therapy focuses on the group and on being with others to grow and develop 
emotionally. 
 
9.3.1. Work Therapy 
 
Work therapy is an excellent type of therapy that offers patients an opportunity to be 
productive. Patients work together to accomplish various goals that are clearly outlined to 
them in the beginning of the sessions. An activity program with adequate leadership and 
personnel is established. Activities range from food preparation, landscaping, dressmaking, 
carpentry etc… 
 
9.3.2. Art Therapy 
 
Art therapy is a prospective outlet for people who don’t know how to verbalize their feelings 
during traditional psychotherapy sessions. It allows patients to set goals and create in a safe 
space under the supervision of a professional. Various techniques are used such as painting, 
drawing, sculpting or other types of artwork. 
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10. COURSE AND PROGNOSIS 
 
 
In more than half of patients, OCD begins with an abrupt appearance of symptoms. The 
first symptoms usually begin after some stressful life event, such as the death of a loved one. 
Diagnosis is not made right away since the majority of patients successfully hide their 
disorder, especially those with the milder form. OCD is usually a chronic disorder with a 
fluctuating course in most of patients. A study conducted by Rasmussen and Eisen in 1992 
reported that 85 % of OCD patients had a continuous fluctuating course, 10 % had a 
deteriorative course and 2 % were classified as episodic (Rasmussen and Eisen., 1992). More 
recently in 1999, Skoog and Skoog, in a 40 to 50 year follow up of OCD patients, found that 
overall clinical and subclinical symptoms were still evident in two-thirds of the sample at 
follow-up, and 10 % of the sample showed a deteriorating course (Skoog and Skoog, 1999). 
The majority of patients have both obsessions and compulsions as well as comorbidity with 
other psychiatric disorders. Long-term complications of OCD have to do with the type of 
obsessions or compulsions. For example, constant handwashing can cause skin breakdown. 
OCD does not usually progress into another mental problem. Complete recovery to the point 
of no longer requiring treatment is considered uncommon. However, if proper treatment is 
started OCD can be managed and controlled and the patient can have an excellent quality of 
life. 
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